Voting Result along with scrutinizer report for 31st AGM of the COmpany
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Parmax Pharma held its 31st AGM on September 30, 2025 at its registered office in Rajkot, Gujarat (03:30 PM to 03:54 PM). Three ordinary resolutions were put to vote via remote e-voting (Sept 27–29) and physical poll: (1) adoption of audited financial statements for FY ended March 31, 2025 — passed with 99.9999% in favor; (2) re-appointment of Mr. Umang Alkesh Gosalia (Managing Director, DIN: 05153830) as Director retiring by rotation — passed with 99.9996% in favor; (3) appointment of Mr. Samsad Alam Khan as Secretarial Auditor — passed with 99.9999% in favor. Of the 37,41,300 total outstanding shares, only about 31% were polled. The promoter group holding 11,52,450 shares (~30.8%) did not vote on any resolution, while 15 public shareholders attended in person. Scrutinizer Samsad Alam Khan certified the e-voting process as fair and transparent.
This is a routine regulatory filing confirming that all AGM resolutions passed with overwhelming shareholder support. The notable observation is the promoter group's non-participation in voting despite holding a meaningful stake, though this does not affect the validity of the resolutions. No material impact on share price is expected.